MUDr. Michal Šitina, Ph.D., M.Sc.
Assistant professor, Department of Pathophysiology
Correspondence Address:
Kamenice 753/5, 625 00 Brno
E‑mail: |
---|
Total number of publications: 10
2024
-
Euglykemická ketoacidóza asociovaná se SGLT2 inhibitory a DPP4 inhibitory - rozbor kazuistik
Anesteziologie a intenzivní medicína, year: 2024, volume: 35, edition: 2, DOI
-
Optimal hematocrit theory: a review
JOURNAL OF APPLIED PHYSIOLOGY, year: 2024, volume: 137, edition: 3, DOI
-
Pathogenesis of euglycemic ketoacidosis associated with SGLT2 inhibitors
Anesteziologie a intenzivní medicína, year: 2024, volume: 35, edition: 2, DOI
2023
-
Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis
BMC ENDOCRINE DISORDERS, year: 2023, volume: 23, edition: 1, DOI
-
Hepcidin and ferritin levels as markers of immune cell activation during septic shock, severe COVID-19 and sterile inflammation
FRONTIERS IN IMMUNOLOGY, year: 2023, volume: 14, edition: January 2023, DOI
-
Prognostic significance of early acute kidney injury in COVID-19 patients requiring mechanical ventilation: a single-center retrospective analysis
RENAL FAILURE, year: 2023, volume: 45, edition: 1, DOI
2022
-
Increased occurrence of Treponema spp. and double-species infections in patients with Alzheimer's disease
Science of the Total Environment, year: 2022, volume: 844, edition: October 2022, DOI
-
Kinetics of Biomarkers of Oxidative Stress in Septic Shock: A Pilot Study
Antioxidants, year: 2022, volume: 11, edition: 4, DOI
-
Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19
Frontiers in Medicine, year: 2022, volume: 9, edition: August 2022, DOI
2021
-
Možnosti využitia Endoglinu ako biomarkeru u pacientov v septickom šoku
Year: 2021, type: Conference abstract